ArticleThe Journal of clinical investigation2022
Concerns about the inverse relationship between baseline HBV DNA and on-treatment hepatocellular carcinoma risk. Reply.
Won-Mook Choi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.